Medical research advances in stages, and certain initiatives attract attention when current treatments show their limits. This is the case in Chinewhere a team from the University of Science and Technology of China (USTC) is evaluating an experimental cell therapy for people with Parkinson’s disease. According to the South China Morning Postthe first results give a glimpse of what this approach could ultimately bring.
Cell therapy and medical technologies
Researchers have developed a method using reprogrammed stem cells to obtain dopaminergic neuron precursors capable of replacing those destroyed by the disease. THE South China Morning Post indicates that the conversion process exceeds 80%, which made it possible to conduct a phase I clinical trial. Six patients received an injection of cells called NCR201, produced by the company Nuwacell founded by Yu Junying, and implemented using a neuronavigation robot guided by algorithms.
Parkinson’s disease – symptoms and current limitations
The disease causes tremors, muscle rigidity, slowed movements and difficulty with balance. These disorders increase the risk of falls and gradually complicate daily life. Medications alleviate some of the symptoms but do not prevent the loss of dopaminergic neurons. Over time, their effectiveness varies and motor fluctuations appear, which pushes researchers to explore avenues capable of restoring certain functions.
One of the cases relayed by the South China Morning Post concerns a 37-year-old patient, affected very early. Three months after the transplant performed in Hefei, his tremors and rigidity significantly decreased. His clinical score, initially high, fell to the point of approaching that observed in a non-ill person. Brain imaging suggests effective integration of implanted cells.
Chinese specialists remain cautious: the survival time of the cells and the stability of their effects must still be verified. According to Shi Jiongother patients will be recruited to confirm these initial results. THE South China Morning Post recalls that a team from Shanghai observed similar improvements, which could indicate a potential to be explored, even if the lasting effectiveness of this therapy remains to be established.
